...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith MD&A posted to SEDAR 8/23/18

Thanks bear.

I would really like an update on the zen3694 trial in terms of how the 3 super star patients are doing, an update on othe patients that seemed to be moving toward the target to see if they have surpassed it, and indication as to who (typologies) of who it works well with and what is known about when it doesn't work and I'd like to see Don's response to GAC's question addressed to Mr Moon.

I'd also like to see the status and priority regarding liquidity.

GLTA

Toinv

Share
New Message
Please login to post a reply